. Author manuscript; available in PMC: 2017 Nov 1.

Published in final edited form as: Am J Transplant. 2016 Jul 7;16(11):3121–3130. doi: 10.1111/ajt.13865

Table 1.

Effects of DSA and NK cells (endogenous versus adoptively transferred) on the frequency of chronic allograft vasculopathy.

Group	Donor	Recipient	Treatment	Frequency of CAV
1	C3H	B6rag−/−	No Rx	0/5
2			α-H2^k	5/6
3	C3H	B6.rag−/−γc−/−	No Rx	0/5
4			α-H2^k	1/5
5			α-H2^k + B6 wild-type NK cells	6/6